IgG oligosaccharide alterations are a novel diagnostic marker for disease activity and the clinical course of inflammatory bowel disease

American Journal of Gastroenterology

Volumn 103, Issue 5, 2008, Pages 1173-1181

  Shinzaki, Shinichiro ^a   Iijima, Hideki ^a   Nakagawa, Takatoshi ^a   Egawa, Satoshi ^a   Nakajima, Sachiko ^a   Ishii, Shuji ^a   Irie, Takanobu ^a   Kakiuchi, Yoshimi ^a   Nishida, Tsutomu ^a   Yasumaru, Masakazu ^a   Kanto, Tatsuya ^a   Tsujii, Masahiko ^a   Tsuji, Shingo ^a   Mizushima, Tsunekazu ^c   Yoshihara, Harumasa ^b   Kondo, Akihiro ^a   Miyoshi, Eiji ^a   Hayashi, Norio ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b OSAKA ROSAI HOSPITAL   (Japan)

^c Department of Cardiology   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 1,4 GALACTOSYLTRANSFERASE; FUNGUS ANTIBODY; GALACTOSYLTRANSFERASE; IMMUNOGLOBULIN G; IMMUNOMODULATING AGENT; INFLIXIMAB; MESALAZINE; MESSENGER RNA; OLIGOSACCHARIDE; SACCHAROMYCES CEREVISIAE ANTIBODY; SALAZOSULFAPYRIDINE;

ARTICLE; CONTROLLED STUDY; CROHN DISEASE; DISEASE ACTIVITY; DISEASE COURSE; DISEASE SEVERITY; ENTERITIS; ENZYME ACTIVITY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; REMISSION; RHEUMATOID ARTHRITIS; ULCERATIVE COLITIS;

ADULT; BIOLOGICAL MARKERS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COLITIS, ULCERATIVE; CROHN DISEASE; FEMALE; HUMANS; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS;

EID: 43549098797     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2007.01699.x     Document Type: Article

References (39)

1. Shanahan F. Crohn's disease. Lancet 2002 359 : 62 9.
2. Blumberg RS, Saubermann LJ, Strober W. Animal models of mucosal inflammation and their relation to human inflammatory bowel disease. Curr Opin Immunol 1999 11 : 648 56.
3. Reumaux D, Sendid B, Poulain D, et al. Serological markers in inflammatory bowel diseases. Best Pract Res Clin Gastroenterol 2003 17 : 19 35.
4. McKenzie H, Main J, Pennington CR, et al. Antibody to selected strains of Saccharomyces cerevisiae (baker's and brewer's yeast) and Candida albicans in Crohn's disease. Gut 1990 31 : 536 8.
5. Sutton CL, Kim J, Yamane A, et al. Identification of a novel bacterial sequence associated with Crohn's disease. Gastroenterology 2000 119 : 23 31.
6. Cohavy O, Bruckner D, Gordon LK, et al. Colonic bacteria express an ulcerative colitis pANCA-related protein epitope. Infect Immun 2000 68 : 1542 8.
7. Landers CJ, Cohavy O, Misra R, et al. Selected loss of tolerance evidenced by Crohn's disease-associated immune responses to auto- and microbial antigens. Gastroenterology 2002 123 : 689 99.
8. Lodes MJ, Cong Y, Elson CO, et al. Bacterial flagellin is a dominant antigen in Crohn disease. J Clin Invest 2004 113 : 1296 306.
9. Sox HC Jr., Hood L. Attachment of carbohydrate to the variable region of myeloma immunoglobulin light chains. Proc Natl Acad Sci U S A 1970 66 : 975 82.
10. Takahashi N, Ishii I, Ishihara H, et al. Comparative structural study of the N-linked oligosaccharides of human normal and pathological immunoglobulin G. Biochemistry 1987 26 : 1137 44.
11. Mizuochi T, Taniguchi T, Shimizu A, et al. Structural and numerical variations of the carbohydrate moiety of immunoglobulin G. J Immunol 1982 129 : 2016 20.
12. Kondo A, Hosokawa Y, Kiso M, et al. Analysis of oligosaccharides of human IgG from serum of leukemia patients. Biochem Mol Biol Int 1994 32 : 897 902.
13. Parekh RB, Dwek RA, Sutton BJ, et al. Association of rheumatoid arthritis and primary osteoarthritis with changes in the glycosylation pattern of total serum IgG. Nature 1985 316 : 452 7.
14. Tomana M, Schrohenloher RE, Koopman WJ, et al. Abnormal glycosylation of serum IgG from patients with chronic inflammatory diseases. Arthritis Rheum 1988 31 : 333 8.
15. Bond A, Alavi A, Axford JS, et al. The relationship between exposed galactose and N-acetylglucosamine residues on IgG in rheumatoid arthritis (RA), juvenile chronic arthritis (JCA) and Sjogren's syndrome (SS). Clin Exp Immunol 1996 105 : 99 103.
16. Ichikawa Y, Yamada C, Horiki T, et al. Anti-agalactosyl IgG antibodies and isotype profiles of rheumatoid factors in Sjogren's syndrome and rheumatoid arthritis. Clin Exp Rheumatol 1998 16 : 709 15.
17. Das H, Atsumi T, Fukushima Y, et al. Diagnostic value of antiagalactosyl IgG antibodies in rheumatoid arthritis. Clin Rheumatol 2004 23 : 218 22.
18. Lennard-Jones JE. Classification of inflammatory bowel disease. Scand J Gastroenterol Suppl 1989 170 : 2 6 discussion 16-9.
19. Podolsky DK. Inflammatory bowel disease. N Engl J Med 1991 325 : 928 37.
20. Podolsky DK. Inflammatory bowel disease. N Engl J Med 1991 325 : 1008 16.
21. Gasche C, Scholmerich J, Brynskov J, et al. A simple classification of Crohn's disease: Report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998. Inflamm Bowel Dis 2000 6 : 8 15.
22. Best WR, Becktel JM, Singleton JW, et al. Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. Gastroenterology 1976 70 : 439 44.
23. Rachmilewitz D. Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: A randomised trial. BMJ 1989 298 : 82 6.
24. Kruis W, Schreiber S, Theuer D, et al. Low dose balsalazide (1.5 g twice daily) and mesalazine (0.5 g three times daily) maintained remission of ulcerative colitis but high dose balsalazide (3.0 g twice daily) was superior in preventing relapses. Gut 2001 49 : 783 9.
25. Mullen AC, Hutchins AS, High FA, et al. Hlx is induced by and genetically interacts with T-bet to promote heritable T(H)1 gene induction. Nat Immunol 2002 3 : 652 8.
26. Fujii S, Nishiura T, Nishikawa A, et al. Structural heterogeneity of sugar chains in immunoglobulin G. Conformation of immunoglobulin G molecule and substrate specificities of glycosyltransferases. J Biol Chem 1990 265 : 6009 18.
27. Morita N, Hase S, Ikenaka K, et al. Pyridylamino sugar chain as an acceptor for galactosyltransferase. J Biochem (Tokyo) 1988 103 : 332 5.
28. Hase S, Ibuki T, Ikenaka T. Reexamination of the pyridylamination used for fluorescence labeling of oligosaccharides and its application to glycoproteins. J Biochem (Tokyo) 1984 95 : 197 203.
29. Beck JR, Shultz EK. The use of relative operating characteristic (ROC) curves in test performance evaluation. Arch Pathol Lab Med 1986 110 : 13 20.
30. Zweig MH, Campbell G. Receiver-operating characteristic (ROC) plots: A fundamental evaluation tool in clinical medicine. Clin Chem 1993 39 : 561 77.
31. Bond A, Alavi A, Axford JS, et al. A detailed lectin analysis of IgG glycosylation, demonstrating disease specific changes in terminal galactose and N-acetylglucosamine. J Autoimmun 1997 10 : 77 85.
32. Dube R, Rook GA, Steele J, et al. Agalactosyl IgG in inflammatory bowel disease: Correlation with C-reactive protein. Gut 1990 31 : 431 4.
33. Dubinsky MC, Lin YC, Dutridge D, et al. Serum immune responses predict rapid disease progression among children with Crohn's disease: Immune responses predict disease progression. Am J Gastroenterol 2006 101 : 360 7.
34. Keusch J, Lydyard PM, Delves PJ. The effect on IgG glycosylation of altering beta1,4-galactosyltransferase-1 activity in B cells. Glycobiology 1998 8 : 1215 20.
35. Jeddi PA, Bodman-Smith KB, Lund T, et al. Agalactosyl IgG and beta-1,4-galactosyltransferase gene expression in rheumatoid arthritis patients and in the arthritis-prone MRL lpr/lpr mouse. Immunology 1996 87 : 654 9.
36. Rademacher TW, Williams P, Dwek RA. Agalactosyl glycoforms of IgG autoantibodies are pathogenic. Proc Natl Acad Sci U S A 1994 91 : 6123 7.
37. Malhotra R, Wormald MR, Rudd PM, et al. Glycosylation changes of IgG associated with rheumatoid arthritis can activate complement via the mannose-binding protein. Nat Med 1995 1 : 237 43.
38. Dong X, Storkus WJ, Salter RD. Binding and uptake of agalactosyl IgG by mannose receptor on macrophages and dendritic cells. J Immunol 1999 163 : 5427 34.
39. Rudd PM, Elliott T, Cresswell P, et al. Glycosylation and the immune system. Science 2001 291 : 2370 6.